Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Wednesday, March 6, 2013
UMDNJ settles over charges they excluded applicants with hepatitis B
Under the settlement, UMDNJ will adopt a disability rights policy and allow the applicants to enroll. It also will provide ADA training to its employees and provide the applicants with $75,000 overall in compensation and tuition credits.